{"transactions":[{"id":933509,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":false,"shares":39784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option was granted on November 1, 2023. 25% of the shares underlying the option vested on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":662814,"derivative":{"exercise_price":9.26,"expiration_date":"2033-11-01","underlying":"Ordinary Shares","underlying_shares":39784},"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":933508,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":60216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option was granted on November 1, 2023. 25% of the shares underlying the option vested on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":702598,"derivative":{"exercise_price":9.26,"expiration_date":"2033-11-01","underlying":"Ordinary Shares","underlying_shares":60216},"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":933507,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":24362,"price":33.8,"value":823435.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"These shares were sold in multiple transactions at prices ranging from $33.48 per share to $34.31 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":58382,"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":933506,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":15422,"price":33.25,"value":512781.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"These shares were sold in multiple transactions at prices ranging from $32.48 per share to $33.47 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":82744,"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":933505,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":true,"shares":39784,"price":9.26,"value":368399.84,"ownership":{"direct":true},"balance_after":98166,"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":933504,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":19604,"price":32.38,"value":634777.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were sold in multiple transactions at prices ranging from $32.29 per share to $32.58 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":58382,"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":933503,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":39712,"price":31.78,"value":1262047.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were sold in multiple transactions at prices ranging from $31.29 per share to $32.28 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":77986,"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":933502,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":900,"price":30.64,"value":27576.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in multiple transactions at prices ranging from $30.17 per share to $30.85 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":117698,"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":933501,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T22:24:59.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":60216,"price":9.26,"value":557600.16,"ownership":{"direct":true},"balance_after":118598,"source":{"system":"sec-edgar","filing":"0001193125-26-019686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526019686/ownership.xml","form_type":"4"}},{"id":944785,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2026-01-07T23:27:26.000Z","date":"2026-01-07","kind":"grant","planned":true,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares underlying the option will vest on Janaury 2, 2027, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":115000,"derivative":{"exercise_price":35.45,"expiration_date":"2036-01-07","underlying":"Ordinary Shares","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001193125-26-006658","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526006658/ownership.xml","form_type":"4"}},{"id":944784,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-07T23:27:26.000Z","date":"2026-01-07","kind":"grant","planned":true,"acquired":true,"shares":25500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents RSUs, each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU was granted on January 7, 2026 for no consideration."}],"balance_after":58382,"source":{"system":"sec-edgar","filing":"0001193125-26-006658","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526006658/ownership.xml","form_type":"4"}},{"id":944783,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-07T23:27:26.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":5118,"price":33.25,"value":170173.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents pre-arranged sale of shares by the Reporting Person solely to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs) pursuant to sell-to-cover agreement entered into with the Issuer. The sale does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.77 to $33.58 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":32882,"source":{"system":"sec-edgar","filing":"0001193125-26-006658","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526006658/ownership.xml","form_type":"4"}},{"id":1292010,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2025-01-29T22:25:01.000Z","date":"2025-01-28","kind":"exercise","planned":true,"acquired":false,"shares":14900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was granted on November 1, 2023. 25% of the shares underlying the option vested on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":762814,"derivative":{"exercise_price":9.26,"expiration_date":"2033-11-01","underlying":"Ordinary Shares","underlying_shares":14900},"source":{"system":"sec-edgar","filing":"0000950170-25-010594","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025010594/ownership.xml","form_type":"4"}},{"id":1292009,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2025-01-29T22:25:01.000Z","date":"2025-01-27","kind":"exercise","planned":true,"acquired":false,"shares":46983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was granted on November 1, 2023. 25% of the shares underlying the option vested on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":777714,"derivative":{"exercise_price":9.26,"expiration_date":"2033-11-01","underlying":"Ordinary Shares","underlying_shares":46983},"source":{"system":"sec-edgar","filing":"0000950170-25-010594","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025010594/ownership.xml","form_type":"4"}},{"id":1292008,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-29T22:25:01.000Z","date":"2025-01-28","kind":"sale","planned":true,"acquired":false,"shares":3405,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"These shares were sold in multiple transactions at prices ranging from $21.93 per share to $22.41 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0000950170-25-010594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025010594/ownership.xml","form_type":"4"}},{"id":1292007,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-29T22:25:01.000Z","date":"2025-01-28","kind":"sale","planned":true,"acquired":false,"shares":11495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were sold in multiple transactions at prices ranging from $20.93 per share to $21.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":41405,"source":{"system":"sec-edgar","filing":"0000950170-25-010594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025010594/ownership.xml","form_type":"4"}},{"id":1292006,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-29T22:25:01.000Z","date":"2025-01-28","kind":"exercise","planned":true,"acquired":true,"shares":14900,"price":9.26,"value":137974.0,"ownership":{"direct":true},"balance_after":52900,"source":{"system":"sec-edgar","filing":"0000950170-25-010594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025010594/ownership.xml","form_type":"4"}},{"id":1292005,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-29T22:25:01.000Z","date":"2025-01-27","kind":"sale","planned":true,"acquired":false,"shares":13304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were sold in multiple transactions at prices ranging from $23.38 per share to $23.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0000950170-25-010594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025010594/ownership.xml","form_type":"4"}},{"id":1292004,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-29T22:25:01.000Z","date":"2025-01-27","kind":"sale","planned":true,"acquired":false,"shares":33679,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in multiple transactions at prices ranging from $22.38 per share to $23.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."}],"balance_after":51304,"source":{"system":"sec-edgar","filing":"0000950170-25-010594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025010594/ownership.xml","form_type":"4"}},{"id":1292003,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-29T22:25:01.000Z","date":"2025-01-27","kind":"exercise","planned":true,"acquired":true,"shares":46983,"price":9.26,"value":435062.58,"ownership":{"direct":true},"balance_after":84983,"source":{"system":"sec-edgar","filing":"0000950170-25-010594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025010594/ownership.xml","form_type":"4"}},{"id":1308331,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-07T22:08:12.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":38000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on January 7, 2025 for no consideration."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0000950170-25-002973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025002973/ownership.xml","form_type":"4"}},{"id":1311138,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2025-01-06T22:53:52.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option will vest on January 2, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":220000,"derivative":{"exercise_price":25.96,"expiration_date":"2035-01-02","underlying":"Ordinary Shares","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0000950170-25-002369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025002369/ownership.xml","form_type":"4"}},{"id":1693371,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2024-01-03T22:10:22.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":80000,"derivative":{"exercise_price":11.17,"expiration_date":"2034-01-01","underlying":"Ordinary Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000950170-24-001104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017024001104/ownership.xml","form_type":"4"}},{"id":2942834,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T16:02:43.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option shall vest and become exercisable on April 9, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":102558,"derivative":{"exercise_price":5.88,"expiration_date":"2028-04-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-20-034089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924320034089/doc4.xml","form_type":"4"}},{"id":2942833,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-16T16:02:43.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":2000,"price":35,"value":70000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1473,"source":{"system":"sec-edgar","filing":"0000899243-20-034089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924320034089/doc4.xml","form_type":"4"}},{"id":2942832,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-16T16:02:43.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":2000,"price":5.88,"value":11760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":3473,"source":{"system":"sec-edgar","filing":"0000899243-20-034089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924320034089/doc4.xml","form_type":"4"}},{"id":2948780,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-11T06:20:02.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":92000,"derivative":{"exercise_price":31.83,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0000899243-20-033479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924320033479/doc4.xml","form_type":"4"}},{"id":2973322,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T17:00:18.000Z","date":"2020-11-17","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option shall vest and become exercisable on April 9, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":104558,"derivative":{"exercise_price":5.88,"expiration_date":"2028-04-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-059443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120059443/doc4.xml","form_type":"4"}},{"id":2973321,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-19T17:00:18.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":1666,"price":30,"value":49980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1473,"source":{"system":"sec-edgar","filing":"0001209191-20-059443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120059443/doc4.xml","form_type":"4"}},{"id":2973320,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-19T17:00:18.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":2000,"price":30,"value":60000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":3139,"source":{"system":"sec-edgar","filing":"0001209191-20-059443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120059443/doc4.xml","form_type":"4"}},{"id":2973319,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-19T17:00:18.000Z","date":"2020-11-17","kind":"exercise","acquired":true,"shares":2000,"price":5.88,"value":11760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":5139,"source":{"system":"sec-edgar","filing":"0001209191-20-059443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120059443/doc4.xml","form_type":"4"}},{"id":3193304,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-27T16:11:50.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":1473,"price":10.1,"value":14877.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the ESPP for the ESPP purchase period of September 2, 2019 through February 28, 2020. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 28, 2020."}],"balance_after":3139,"source":{"system":"sec-edgar","filing":"0001209191-20-021376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120021376/doc4.xml","form_type":"4"}},{"id":3193303,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-27T16:11:50.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":1666,"price":12.75,"value":21241.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's 2018 Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of February 13, 2019 through August 30, 2019.  This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 13, 2019."}],"balance_after":1666,"source":{"system":"sec-edgar","filing":"0001209191-20-021376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120021376/doc4.xml","form_type":"4"}},{"id":3334010,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-20T19:36:31.000Z","date":"2019-12-19","kind":"grant","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2021, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":16.1,"expiration_date":"2029-12-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-029852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319029852/doc4.xml","form_type":"4"}},{"id":3556740,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":69005,"kind":"person","name":"Somaiya Mayur Ian","position":1,"cik":"0001760303","reported_name":"Somaiya Mayur Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-12T16:06:52.000Z","date":"2019-04-11","kind":"grant","acquired":true,"shares":152307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":152307,"derivative":{"exercise_price":16.11,"expiration_date":"2029-04-10","underlying":"Common Stock","underlying_shares":152307},"source":{"system":"sec-edgar","filing":"0001750019-19-000022","document":"wf-form4_155509959836134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000175001919000022/wf-form4_155509959836134.xml","form_type":"4"}}]}